Terai Shuji
Affiliate Master
Yamaguchi University
Currents status and prospects of autologous bone marrow cell infusion therapy for liver cirrhosis patients
The bulletin of the Yamaguchi Medical School Volume 56 Issue 1-2
Page 1-3
published_at 2009
Title
Currents status and prospects of autologous bone marrow cell infusion therapy for liver cirrhosis patients
Source Identifiers
Creator Keywords
ABMi therapy
bone marrow cell
regeneration
cell therapy
liver cirrhosis
We developed a novel cell therapy (ABMi therapy) using autologous bone marrow cells for liver cirrhosis patients. Our study depends on the findings from basic studies using GFP/CCl4 models. Beginning in November 2003, we started clinical trials of ABMi therapy and found it to be safe and effective for liver cirrhosis patients. Multicenter trials in Japan and Korea have also shown the effectiveness of ABMi therapy. In this review, we discuss translational research for the development of ABMi therapy for liver cirrhosis patients.
Languages
eng
Resource Type
departmental bulletin paper
Publishers
Yamaguchi University School of Medicine
Date Issued
2009
File Version
Version of Record
Access Rights
open access
Relations
[isVersionOf]
[URI]http://ds.cc.yamaguchi-u.ac.jp/~bulletin/index.html
Schools
大学院医学系研究科（医学）